PsychiatryNews.net

Psychiatry Xagena

Xagena Mappa
Medical Meeting
Ematobase.it
Xagena Salute

Search results for "Zyprexa"

The FDA ( Food and Drug Administration ) issued a public health advisory to alert health care providers, patients, and patient caregivers to new safety information concerning an unapproved ( i.e., “o ...


A third of patients treated for schizophrenia who stop taking their medication early do so because they do not feel any significant improvement or because their symptoms are worsening. A study publ ...


A study, published in The American Journal of Psychiatry, has shown that for young people who clearly seem to be developing early signs of schizophrenia, treatment with the antipsychotic drug Olanzapi ...


Atypical antipsychotics have benefits for psychiatric illness in children and adolescents but are often accompanied by significant weight gain, possibly resulting in type 2 diabetes. Metformin ( Gl ...


Many people, including significant proportions of active duty military personnel and veterans, suffer from post-traumatic stress disorder ( PTSD ), often in conjunction with other injuries or illnesse ...


Second-generation antipsychotic drugs are not necessarily better than the first-generation drug Haloperidol ( Haldol ) at treating a first episode of schizophrenia.Second-generation drugs, introduced ...


Second-generation antipsychotic drugs are not necessarily better than the first-generation drug Haloperidol ( Haldol ) at treating a first episode of schizophrenia.Second-generation drugs, introduced ...


Nearly every child who receives an antipsychotic drug is first prescribed one of the second-generation, or atypical drugs, such as Olanzapine ( Zyprexa ) and Risperidone ( Risperdal ). However, there ...


Asenapine ( Saphris ) met the primary endpoint over one year of treatment in an extension study in patients with predominant, persistent negative symptoms of schizophrenia.Negative symptoms of schizop ...


Treatment of bipolar depression is complicated by variable response and risk of switch to mania. Guidance is informed by the strength of evidence rather than by comparative data. Researchers have p ...